Expression, function and regulation of the intercellular adhesion molecule-1 (ICAM-1) on human intestinal epithelial cell lines.

PubWeight™: 1.49‹?› | Rank: Top 4%

🔗 View Article (PMID 1680698)

Published in Eur J Immunol on October 01, 1991

Authors

D Kaiserlian1, D Rigal, J Abello, J P Revillard

Author Affiliations

1: INSERM U 80, CNRS URA 1177 UCBL, Hôpital E. Herriot, Lyon, France.

Articles citing this

A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest (1995) 7.68

Infection of human intestinal epithelial cells with invasive bacteria upregulates apical intercellular adhesion molecule-1 (ICAM)-1) expression and neutrophil adhesion. J Clin Invest (1996) 1.69

Expression and polarization of intercellular adhesion molecule-1 on human intestinal epithelia: consequences for CD11b/CD18-mediated interactions with neutrophils. Mol Med (1996) 1.39

Mediation by NF-kappa B of cytokine induced expression of intercellular adhesion molecule 1 (ICAM-1) in an intestinal epithelial cell line, a process blocked by proteasome inhibitors. Gut (1998) 1.25

Nontypeable Haemophilus influenzae adheres to intercellular adhesion molecule 1 (ICAM-1) on respiratory epithelial cells and upregulates ICAM-1 expression. Infect Immun (2006) 1.22

E-cadherin expression in intestinal epithelium. J Clin Pathol (1995) 1.15

Retracted Activation of intercellular adhesion molecule 1 expression by Helicobacter pylori is regulated by NF-kappaB in gastric epithelial cancer cells. Infect Immun (2000) 1.04

Human intestinal epithelial cells secrete interleukin-1 receptor antagonist and interleukin-8 but not interleukin-1 or interleukin-6. Gut (2000) 1.02

Reduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomas. Br J Cancer (2001) 1.01

Transmigrated neutrophils in the intestinal lumen engage ICAM-1 to regulate the epithelial barrier and neutrophil recruitment. Mucosal Immunol (2013) 1.00

Avenin fails to induce a Th1 response in coeliac tissue following in vitro culture. Gut (2003) 0.99

Altered expression of cell adhesion molecules in uninvolved gut in inflammatory bowel disease. Clin Exp Immunol (1993) 0.97

Transport of nanocarriers across gastrointestinal epithelial cells by a new transcellular route induced by targeting ICAM-1. J Control Release (2012) 0.97

Adhesion molecules intercellular adhesion molecule-1 (ICAM-1), ICAM-3 and B7 are not expressed by epithelium in normal or inflamed colon. Clin Exp Immunol (1995) 0.95

Effects of Escherichia coli and E. coli lipopolysaccharides on the function of human ureteral epithelial cells cultured in serum-free medium. Infect Immun (1993) 0.91

Immunohistochemical analysis of intercellular adhesion molecule-1 expression in human gastric adenoma and adenocarcinoma. Virchows Arch (1997) 0.91

Inflammatory cytokines stimulate the adhesion of colon carcinoma cells to mesothelial monolayers. Dig Dis Sci (2007) 0.89

5-Aminosalicylic acid inhibits the impaired epithelial barrier function induced by gamma interferon. Gut (1996) 0.88

Inhibition of the adherence of T-lymphocytes to epithelial cells by a cyclic peptide derived from inserted domain of lymphocyte function-associated antigen-1. Inflammation (2001) 0.88

Activation by interferon-gamma of expression of ICAM-1 and MHC class II antigens in tumour cells from colorectal carcinomas. Clin Mol Pathol (1995) 0.88

Epithelial adhesion molecules and the regulation of intestinal homeostasis during neutrophil transepithelial migration. Tissue Barriers (2015) 0.87

Celecoxib decreases expression of the adhesion molecules ICAM-1 and VCAM-1 in a colon cancer cell line (HT29). Br J Pharmacol (2007) 0.86

Poly I:C-induced expression of intercellular adhesion molecule-1 in intestinal epithelial cells. Clin Exp Immunol (2009) 0.86

Small bowel transplantation in children: an immunohistochemical study of intestinal grafts. Gut (1995) 0.85

Alteration of intestinal epithelial function by intraepithelial lymphocyte homing. J Gastroenterol (2005) 0.84

Tumour necrosis factor-alpha converting enzyme (TACE) activity in human colonic epithelial cells. Clin Exp Immunol (2004) 0.84

Expression of ICAM-1 in colon epithelial cells: an ultrastructural study performed on in vivo and in vitro models. Virchows Arch (2003) 0.81

What is the role of human intestinal intraepithelial lymphocytes? Clin Exp Immunol (1993) 0.80

Interleukin-8 production by the human colon epithelial cell line HT-29: modulation by interleukin-13. Br J Pharmacol (1996) 0.79

Neutrophil interactions with epithelial-expressed ICAM-1 enhances intestinal mucosal wound healing. Mucosal Immunol (2016) 0.79

Immunohistochemical localisation of intercellular adhesion molecule-1 in follicle associated epithelium of Peyer's patches. Gut (1994) 0.78

Hypoxia Decreases Invasin-Mediated Yersinia enterocolitica Internalization into Caco-2 Cells. PLoS One (2016) 0.78

Interferon gamma downregulates IL-8 production in primary human colonic epithelial cells without induction of apoptosis. Int J Colorectal Dis (2004) 0.77

Articles by these authors

(truncated to the top 100)

With a little help from a friend: increasing HIV transduction of monocyte-derived dendritic cells with virion-like particles of SIV(MAC). Gene Ther (2006) 2.24

The gel test: a new way to detect red cell antigen-antibody reactions. Transfusion (1990) 1.96

Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells. J Clin Invest (1998) 1.79

Mechanisms involved in antithymocyte globulin immunosuppressive activity in a nonhuman primate model. Transplantation (2001) 1.68

Murine enterocytes can present soluble antigen to specific class II-restricted CD4+ T cells. Eur J Immunol (1989) 1.63

Distribution of cells binding erythrocyte-antibody (EA) complexes in human lymphoid populations. Scand J Immunol (1976) 1.53

Major histocompatibility complex class I-restricted CD8+ T cells and class II-restricted CD4+ T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene. Eur J Immunol (1995) 1.47

Long-term culture of human bone marrow. I. characterization of adherent cells in flow cytometry. Exp Hematol (1990) 1.45

T-lymphocytes and serum inhibitors of cell-mediated immunity in renal insufficiency. Nephron (1975) 1.37

Modification of human long-term bone marrow cultures: establishment of a functional stromal microenvironment devoid of myeloid progenitors. Eur J Haematol (1992) 1.37

Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome. Blood (1998) 1.36

A human T-independent B lymphocyte mitogen extracted from Nocardia opaca. J Immunol (1976) 1.33

Changes of Fcgamma receptor-related properties induced by interaction of human lymphocytes with insoluble immune complexes. J Immunol (1977) 1.30

Sex steroid receptors in peripheral T cells: absence of androgen receptors and restriction of estrogen receptors to OKT8-positive cells. J Immunol (1983) 1.30

Study of human T and B lymphocytes with heterologous antisera. I Preparation, specificity and properties of antisera. Immunology (1976) 1.29

Serum beta2-microglobulin in hemodialyzed patients. Nephron (1978) 1.23

Induction of Fas (Apo-1, CD95)-mediated apoptosis of activated lymphocytes by polyclonal antithymocyte globulins. Blood (1998) 1.18

Surgical anatomy of the infratemporal fossa: the styloid diaphragm revisited. Neurosurgery (1998) 1.16

Distribution of androgen and estrogen receptors among lymphoid and haemopoietic cell lines. Leuk Res (1985) 1.15

Suppression of mitogen-induced peripheral B cell differentiation by soluble Fc gamma receptors released from lymphocytes. Eur J Immunol (1980) 1.14

Kinetics of plasma membrane and mitochondrial alterations in cells undergoing apoptosis. Cytometry (1995) 1.13

Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism. Br J Cancer (2009) 1.12

Anti-beta2-microglobulin lymphocytotoxic autoantibodies in systemic lupus erythematosus. J Immunol (1979) 1.10

T-dependence of human B lymphocyte proliferative response to mitogens. Int Arch Allergy Appl Immunol (1976) 1.09

Unexpected lack of reactivity of allogeneic anti-Ia monoclonal antibodies with MHC class II molecules expressed by mouse intestinal epithelial cells. J Immunol (1993) 1.09

Study of human T and B lymphocytes with heterologous antisera. III. Immunofluorescence studies on tonsil sections. Immunology (1978) 1.08

Zygomatic-transmandibular approach for giant tumors of the infratemporal fossa and parapharyngeal space. Neurosurgery (1999) 1.08

Late evolution of serum immunoreactive parathyroid hormones, calcitonin and plasma 25-hydroxy cholecalciferol concentrations in very low birthweight infants. Acta Paediatr Scand (1981) 1.07

Antibodies against functional leukocyte surface molecules in polyclonal antilymphocyte and antithymocyte globulins. Transplantation (1991) 1.07

Distinct subsets of dendritic cells resembling dermal DCs can be generated in vitro from monocytes, in the presence of different serum supplements. J Immunol Methods (2000) 1.06

Antibody-dependent cell cytoxicity (ADCC). Characterization of 'killer' cells in human lymphoid organs. Scand J Immunol (1976) 1.06

First human hand transplantation. Case report. Transpl Int (2000) 1.05

Mechanisms of action of methotrexate. Immunopharmacology (2000) 1.05

Beta 2-microglobulin-associated amyloidosis in chronic haemodialysis patients. Lancet (1986) 1.04

Clinical and laboratory features of canine lupus syndromes. Arthritis Rheum (1980) 1.03

Detection of virus-specific IgA antibodies in serum of kidney transplant patients with recurrent cytomegalovirus infection by enzymeimmuno and radioimmunoassay techniques. Clin Exp Immunol (1982) 1.02

Studies of anti-lymphocyte globulins made from thoracic duct lymphocytes. Transplant Proc (1969) 1.02

The animal lectin galectin-3 interacts with bacterial lipopolysaccharides via two independent sites. J Immunol (1996) 1.01

Caspase-dependent ceramide production in Fas- and HLA class I-mediated peripheral T cell apoptosis. J Biol Chem (1998) 1.00

Active and passive re-expression of Fc gamma receptors on human lymphocytes. Eur J Immunol (1980) 1.00

Detection of specific IgA antibodies in serum of kidney transplant patients with recurrent cytomegalovirus infection. Intervirology (1981) 1.00

Methylation patterns of long interspersed repeated DNA and alphoid repetitive DNA from human cell lines and tumors. Anticancer Res (1992) 0.99

Selective suppression of human B lymphocyte differentiation into IgG-producing cells by soluble Fc gamma receptors. J Immunol (1982) 0.99

Insoluble immune complexes suppress mitogen-induced proliferation of human T lymphocytes bearing Fc gamma receptors. Cell Immunol (1979) 0.99

Inhibition of the mixed lymphocyte reaction by antibodies. Transplant Proc (1972) 0.99

beta 2-Microglobulin and beta 2-microglobulin-binding proteins in inflammatory diseases. Eur J Rheumatol Inflamm (1982) 0.96

[Technic, surveillance and value of the drainage of the thoracic duct, executed in view of a renal transplantation]. J Chir (Paris) (1969) 0.96

Expression of receptors for IgA on mitogen-stimulated human T lymphocytes. Eur J Immunol (1988) 0.96

[Application of the gel test using and anti-IgA antiglobulin for the immunologic diagnosis of autoimmune hemolytic anemia with a negative direct Coombs test]. Transfus Clin Biol (1999) 0.96

CD4 antibody treatment of severe psoriasis. Lancet (1991) 0.96

P53-mediated upregulation of DcR1 impairs oxaliplatin/TRAIL-induced synergistic anti-tumour potential in colon cancer cells. Oncogene (2008) 0.96

Anti-CD4 monoclonal antibody therapy in severe psoriasis. J Autoimmun (1992) 0.95

Flow cytometry analysis of T lymphocytes in sarcoidosis. Am J Med (1982) 0.94

A rosette technique for identification of human mononuclear cells bearing Fc receptors. Biomedicine (1975) 0.93

Estrogen and progesterone receptors in some human myeloma cell lines and murine hybridomas. J Steroid Biochem (1988) 0.93

Transfer factor therapy in immuno-deficiencies. Biomedicine (1973) 0.92

Immunophenotype of the canine transmissible venereal tumour. Vet Immunol Immunopathol (1997) 0.92

The clinical usefulness of the measurement of cytokines. Clin Chem Lab Med (2000) 0.92

Canine systemic lupus erythematosus. I: A study of 75 cases. Lupus (1992) 0.92

Beta-2-microglobulin and HLA-related glycoproteins in human urine and serum. Contrib Nephrol (1981) 0.92

The topoisomerase inhibitors camptothecin and etoposide induce a CD95-independent apoptosis of activated peripheral lymphocytes. Cell Death Differ (2000) 0.91

Anthracyclines trigger apoptosis of both G0-G1 and cycling peripheral blood lymphocytes and induce massive deletion of mature T and B cells. Cancer Res (2000) 0.91

Fas-independent apoptosis of activated T cells induced by antibodies to the HLA class I alpha1 domain. Blood (1997) 0.91

Complexes of alpha 1-microglobulin and monomeric IgA in multiple myeloma and normal human sera. Mol Immunol (1985) 0.91

Tear concentrations of azithromycin following topical administration of a single dose of azithromycin 0.5%, 1.0%, and 1.5% eyedrops (T1225) in healthy volunteers. Eur J Ophthalmol (2008) 0.91

Alterations in polymeric immunoglobulin receptor expression and secretory component levels in bladder carcinoma. Urol Res (1991) 0.90

Modulation of polyclonally activated human peripheral B cells by aggregated IgG and by IgG-binding factors: differential effect on IgG subclass synthesis. J Immunol (1984) 0.90

Elevation of cyclic adenosine monophosphate levels independently down regulates IL-1, IL-2, and IL-2 receptor (CD25) syntheses. Int J Immunopharmacol (1990) 0.90

Peptones stimulate cholecystokinin secretion and gene transcription in the intestinal cell line STC-1. Endocrinology (1997) 0.90

Immunological effects of high dose administration of anti-CD4 antibody in rheumatoid arthritis patients. J Autoimmun (1991) 0.89

Apoptosis without decrease of cell DNA content. FEBS Lett (1995) 0.89

[Drainage of the thoracic duct before transplantation in patients with chronic renal insufficiency]. Nouv Rev Fr Hematol (1969) 0.89

Ganciclovir ophthalmic gel (Virgan; 0.15%) in the treatment of herpes simplex keratitis. Cornea (1997) 0.89

Blocking antibodies eluted from human placenta. Transplant Proc (1973) 0.89

Leukocyte function-associated antigen-1 expression on peripheral blood mononuclear cell subsets in HIV-1 seropositive patients. Clin Immunol Immunopathol (1990) 0.89

Purification of alpha 1-microglobulin produced by human hepatoma cell lines. Biochemical characterization and comparison with alpha 1-microglobulin synthesized by human hepatocytes. Eur J Biochem (1987) 0.88

Serum levels of beta-2-microglobulin--a new marker of activity in Crohn's disease. N Engl J Med (1979) 0.88

[Efficacy and safety of substituting a twice-daily regimen of timolol with a single daily instillation of nonpreserved beta-blocker in patients with chronic glaucoma or ocular hypertension]. J Fr Ophtalmol (2003) 0.88

[Decrease of erythrocyte receptors for the C3b fragment of complement in acquired immunodeficiency syndrome]. Presse Med (1988) 0.88

A rapid one-stage whole-blood HPA-1a phenotyping assay using a recombinant monoclonal IgG1 anti-HPA-1a. Br J Haematol (2000) 0.88

Polymeric Ig receptor expression in hepatocellular carcinoma. Eur J Cancer (1992) 0.88

Inhibition of mixed lymphocyte culture by alloantibodies in renal transplantation and in pregnancy. Transplant Proc (1973) 0.87

Characterization of monoclonal antihuman-B-cell antibody BL13 as an anti-C3d-receptor (CR2) antibody. Scand J Immunol (1986) 0.87

Human T cells require IL-2 but not G1/S transition to acquire susceptibility to Fas-mediated apoptosis. J Immunol (1996) 0.87

Enumeration of CR1 complement receptors on erythrocytes using a new method for detecting low density cell surface antigens by flow cytometry. J Immunol Methods (1987) 0.87

Mechanisms of immunosuppression induced by antithymocyte globulins and OKT3. J Heart Lung Transplant (1996) 0.87

Polyclonal activation of murine B cells by a membrane proteoglycan of Klebsiella pneumoniae. Clin Exp Immunol (1987) 0.87

Sandwich-type ELISA for free and bound secretory component in human biological fluids. J Immunol Methods (1988) 0.87

Canine systemic lupus erythematosus. II: Antinuclear antibodies. Lupus (1992) 0.87

Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies. Br J Haematol (1998) 0.86

Only T alpha or T gamma cells can be triggered by IgG or IgA to suppress the production of the matching Ig class. Eur J Immunol (1986) 0.86

[Proteinuria in renal tubular disorders]. Pathol Biol (1966) 0.86

Demonstration of woodchuck hepatitis virus infection of peripheral blood mononuclear cells by flow cytometry and polymerase chain reaction. J Gen Virol (1992) 0.86

Expression of SNARE proteins in enteroendocrine cell lines and functional role of tetanus toxin-sensitive proteins in cholecystokinin release. FEBS Lett (1998) 0.86

Comparison of radio-immunoassay and lymphocytotoxicity inhibition techniques for the determination of beta2 microglobulin. J Immunol Methods (1976) 0.86

Detection of recurrent cytomegalovirus infection in renal-transplant patients. J Infect Dis (1984) 0.86

Suppression of the late stages of mitogen-induced human B cell differentiation by FC gamma receptors (FC gamma R) released from polymorphonuclear neutrophils. J Immunol (1981) 0.86

[Hemolytic disease of newborn infants caused by anti-Diego antibodies]. Arch Fr Pediatr (1984) 0.85

Profound CD4+ lymphocytopenia in the absence of HIV infection in a patient with visceral leishmaniasis. N Engl J Med (1990) 0.85

Nrh, a human homologue of Nr-13 associates with Bcl-Xs and is an inhibitor of apoptosis. Oncogene (2001) 0.85